Subclinical hypothyroidism means a mildly raised TSH with a normal free T4. The thyroid is still delivering enough hormone, but the pituitary is having to push harder — a slightly elevated TSH — to get it. For most people whose TSH sits up to about 10 mIU/L, guidelines from the American Thyroid Association and others do not recommend starting levothyroxine automatically, because the best trials found that treating mild cases did not make people feel better. The honest answer here is not a yes or a no. It is a framework — and that framework is the answer.

What exactly is subclinical hypothyroidism?

Your thyroid makes hormones (mainly T4) that set your body's metabolic pace. The pituitary gland monitors those levels and releases TSH to tell the thyroid how hard to work. When the thyroid starts to struggle, TSH rises first — before T4 falls — because a higher TSH is exactly what keeps T4 in the normal range. That in-between state is what "subclinical" describes.

How the thyroid states compare on blood tests (reference values, not a diagnosis)
StateTSHFree T4What it means
Normal~0.4–4.0 mIU/LNormalThyroid keeping pace easily
Subclinical hypothyroidismMildly raised (above range, often up to ~10)NormalOutput still normal, but the gland is working harder
Overt hypothyroidismClearly raised (often >10)LowOutput has fallen; treatment usually recommended

Reference ranges vary from lab to lab, and the upper TSH limit reported can differ (commonly 4.0–4.5 mIU/L). That variation matters when a result lands just over the line. You can walk through what your own numbers mean with our lab results decoder, and see the fuller picture of how the panel is run in thyroid testing explained.

Why isn't a mildly high TSH automatically treated?

This is where good evidence overturns intuition. The influential TRUST trial, published in the New England Journal of Medicine in 2017, randomized 737 adults aged 65 and older with subclinical hypothyroidism (TSH roughly 4.6–20 mIU/L, normal free T4) to either levothyroxine or a placebo. After a year, the levothyroxine group's TSH normalized — but their hypothyroid symptoms and tiredness scores were no better than the placebo group's. Later analyses from the same programme found no benefit for mood, cardiac function, or fatigability either.

The practical takeaway: normalizing a number on a lab report is not the same as helping a person feel well. For mild subclinical hypothyroidism, chasing the TSH with medication frequently does neither — and levothyroxine is a lifelong daily commitment with its own monitoring and interactions. That is why "watch and repeat" is a legitimate, evidence-based plan, not a brush-off.

What actually changes the decision?

Several specific factors genuinely tip the balance toward treating. A prescriber weighs them together, not in isolation.

Factors that lean toward treating versus watching (prescriber-led — this is not medical advice)
FactorLeans toward treatmentLeans toward watch & repeat
TSH levelAbove ~10 mIU/LMildly raised, up to ~10
Thyroid (TPO) antibodiesPositive — higher chance of progressingNegative
SymptomsClear, consistent hypothyroid symptomsNone, or explained by something else
Pregnancy / trying to conceiveYes — lower threshold, matters for the pregnancyNot applicable
AgeYounger adultsOlder adults (treated more conservatively)
Repeat resultStill raised weeks laterBack to normal on recheck

A TSH above 10 is the clearest line. The annual rate of progressing to overt hypothyroidism is far higher above 10 than in the 5–10 range, and most guidelines recommend treating a confirmed TSH over 10 in adults up to about 70.

TPO antibodies signal autoimmune (Hashimoto's) thyroid activity and roughly double the yearly risk of progression — about 4.3% per year with antibodies versus 2.1% without. Important honesty here: a positive antibody test on its own is not a disease and does not by itself mean you need medication. It shifts the odds, which is why it earns closer follow-up rather than an automatic prescription. See Hashimoto's disease for what antibodies do and don't tell you.

Why does pregnancy change everything?

Pregnancy is the setting where treating mild subclinical hypothyroidism most clearly matters. The developing baby depends on maternal thyroid hormone early on, and untreated subclinical hypothyroidism is associated with higher risks of miscarriage and preterm delivery. The 2017 ATA pregnancy guidelines set a lower bar: levothyroxine is recommended for antibody-positive women with an elevated TSH and for antibody-negative women with a TSH above 10, and it may be considered for antibody-positive women with a TSH above 2.5. If you are pregnant or trying to conceive, a borderline TSH is a reason to be tested and reviewed promptly rather than watched.

Repeat the test before you act

TSH is not a fixed number. It swings with time of day, recent illness, some medications, and ordinary lab-to-lab variation, and a single reading just over the top of the range often drifts back on its own. Guidelines advise repeating an abnormal TSH — typically a few weeks to a couple of months later, usually with free T4 and, on the first workup, TPO antibodies — before labeling anyone or starting treatment. A mildly high TSH is common, and in many people it simply does not progress.

The midlife trap: thyroid or menopause?

Here is the tension that catches so many women in their 40s and 50s. Fatigue, weight change, low mood, brain fog, poor sleep, and feeling cold are classic hypothyroid symptoms — and they are also textbook perimenopause symptoms. When a borderline TSH turns up on the same blood draw, it is tempting to pin everything on the thyroid and start a pill. But if the TSH is only mildly raised, treating it may leave the real driver — the menopause transition — unaddressed, and you feel no better. This is exactly the scenario the TRUST-era evidence warns about. Work through which is which in thyroid or menopause?, and gauge your symptom pattern with our thyroid symptom checker. Neither replaces a proper workup — they help you ask sharper questions.

If you and your prescriber do decide to treat

Treatment, when it is warranted, is levothyroxine — a synthetic version of the T4 your thyroid makes — with follow-up bloods to guide adjustments. We do not publish doses, because dosing is individual and prescriber-led; the goal is your prescriber's, not a number off the internet. Two honest cautions worth knowing: absorption is affected by timing and by other supplements (calcium, iron, and others), covered in levothyroxine and supplements; and combination T3, desiccated ("natural") thyroid, and compounded thyroid preparations are not recommended over standard levothyroxine by the major thyroid societies. If a mild case is treated on a trial basis and symptoms don't improve after the TSH normalizes, that is useful information — it usually means the thyroid was not the cause.

When to see a doctor

See a clinician for a proper thyroid workup — not self-testing alone — if you have:

  • A TSH result above 10 mIU/L, or any raised TSH with a low free T4 (that is overt hypothyroidism, which is treated).
  • You are pregnant, planning pregnancy, or having fertility difficulties and have any abnormal thyroid result — get reviewed promptly.
  • Persistent, worsening symptoms — deep fatigue, unexplained weight gain, cold intolerance, constipation, low mood, or hair loss — even if a first TSH was borderline.
  • A positive TPO antibody result or a family history of thyroid disease, so follow-up can be scheduled.
  • A neck swelling, difficulty swallowing, or a visible or palpable thyroid lump.

Bring any home-test or lab printout to the appointment. Lab values are a starting point for a conversation, not a diagnosis you make alone — and the right next step for a borderline TSH is usually a repeat test, not a prescription. Explore more in our thyroid health hub and thyroid and fatigue.